mRNA |
SB-525334 |
CTRPv2 |
pan-cancer |
AAC |
0.073 |
0.05 |
mRNA |
MS-275 |
CTRPv2 |
pan-cancer |
AAC |
0.063 |
0.05 |
mRNA |
Erlotinib |
gCSI |
pan-cancer |
AAC |
-0.12 |
0.05 |
mRNA |
tretinoin:navitoclax (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.068 |
0.05 |
mRNA |
cabozantinib |
CTRPv2 |
pan-cancer |
AAC |
-0.071 |
0.06 |
mRNA |
Parthenolide |
CTRPv2 |
pan-cancer |
AAC |
0.072 |
0.06 |
mRNA |
navitoclax:MST-312 (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.067 |
0.07 |
mRNA |
PX-12 |
CTRPv2 |
pan-cancer |
AAC |
0.052 |
0.07 |
mRNA |
CAL-101 |
CTRPv2 |
pan-cancer |
AAC |
-0.066 |
0.07 |
mRNA |
BRD-A02303741:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.065 |
0.07 |